» Articles » PMID: 39374485

Longitudinal Assessments of Viral Rebound Among People with HIV in South Carolina: a Population-based Cohort Study

Overview
Journal AIDS Care
Publisher Informa Healthcare
Date 2024 Oct 7
PMID 39374485
Authors
Affiliations
Soon will be listed here.
Abstract

Routinely monitoring viral rebound (VR) is important in the life course of people with HIV (PWH). This study examined risk factors for time to the first VR, the number of VRs and their association with VR history in men who have sex with men (MSM). It includes 8176 adult PWH diagnosed from January 2005 to December 2018, followed until July 2021. We used the Cox model for time to the first VR, the Poisson model for a number of VRs, and logistic regression for VR history in MSM. Younger individuals (50-59 years vs 18-29 years, aHR: 0.43, 95% CI: [0.34, 0.55]) were more likely to experience VR. Black individuals (Black vs White, IRR: 1.61, 95% CI [1.38, 1.88]) had more VR, while MSM (MSM vs Heterosexual, IRR: 0.68, 95% CI: [0.57, 0.81]) was negatively associated with number of VsR. Furthermore, individuals engaging illicit drug use (IDU) (aOR: 1.50, 95% CI: [1.03, 2.17]) were more likely to experience VR in the MSM subgroup. This study highlighted the alarming risk factors related to VR among PWH. Tailored intervention should also be deployed for young, Black MSM patients with substance use for more effective and targeted public health strategies concerning VR.

References
1.
Lampe F, Harding R, Smith C, Phillips A, Johnson M, Sherr L . Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010; 54(5):500-5. DOI: 10.1097/QAI.0b013e3181ce6afe. View

2.
Beer L, Bradley H, Mattson C, Johnson C, Hoots B, Shouse R . Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013. J Acquir Immune Defic Syndr. 2016; 73(4):446-453. PMC: 5085853. DOI: 10.1097/QAI.0000000000001125. View

3.
Kwan T, Chan C, Wong N, Lee S . Awareness of HIV functional cure and willingness in participating in related clinical trials: comparison between antiretroviral naïve and experienced men who have sex with men living with HIV. BMC Infect Dis. 2022; 22(1):383. PMC: 9013029. DOI: 10.1186/s12879-022-07346-x. View

4.
Robertson M, Laraque F, Mavronicolas H, Braunstein S, Torian L . Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City. AIDS Care. 2014; 27(2):260-7. DOI: 10.1080/09540121.2014.959463. View

5.
Olatosi B, Zhang J, Weissman S, Hu J, Haider M, Li X . Using big data analytics to improve HIV medical care utilisation in South Carolina: A study protocol. BMJ Open. 2019; 9(7):e027688. PMC: 6661700. DOI: 10.1136/bmjopen-2018-027688. View